![](/img/cover-not-exists.png)
Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate or High Risk of Relapse: Results From the SORCE Randomized Phase III Intergroup Trial
Eisen, Tim, Frangou, Eleni, Oza, Bhavna, Ritchie, Alastair W.S., Smith, Benjamin, Kaplan, Rick, Davis, Ian D., Stockler, Martin R., Albiges, Laurence, Escudier, Bernard, Larkin, James, Bex, Axel, JoniJournal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.20.01800
Date:
October, 2020
File:
PDF, 1.25 MB
2020